Lifesten Health Publishes Groundbreaking Research on Digital Blood Pressure Screening

2–3 minutes

Innovating Preventive Healthcare Through Technology

Lifesten Health has recently published a study in the London Journal of Medical & Health Research (Volume 26 | Issue 1) that explores the accuracy of its AI-powered transdermal optical imaging (TOI) technology for blood pressure measurement. The research highlights how digital health solutions like the Lifesten app can play a critical role in preventive health, especially in resource-limited settings.

Addressing the Global Burden of Non-Communicable Diseases

Non-communicable diseases, including cardiovascular conditions, account for more than 70 percent of deaths worldwide. Early detection and regular monitoring of blood pressure are essential to reduce the risk of hypertension, stroke, and heart disease. Lifesten Health’s digital platform is designed to empower users to monitor their health from anywhere, enabling proactive interventions before serious complications occur.

Study Overview and Methodology

The cross-sectional study was conducted in Kigali, Rwanda, with participants aged 18 to 45. The research specifically targeted high-risk populations using social media campaigns, community outreach, and focused advertising. Each participant underwent blood pressure measurement using both the Lifesten app and a traditional cuff-based device. Data were analyzed using SPSS to assess differences between the two methods and evaluate the potential of TOI technology for reliable health screening.

Key Findings

Among 384 participants, the Lifesten app recorded mean systolic and diastolic blood pressures of 111.45 mmHg and 74.75 mmHg, compared to 116.78 mmHg and 75.71 mmHg using traditional methods. The differences represented 4.56 percent for systolic and 1.27 percent for diastolic readings. In a subgroup of hypertensive participants, the Lifesten app measured slightly lower blood pressure than traditional devices, demonstrating the need for ongoing algorithm refinement. Despite these differences, the study confirms that the Lifesten app shows strong potential for early hypertension screening in communities with limited access to healthcare facilities.

Implications for Preventive Health

This study emphasizes the importance of accessible, scalable digital tools in preventive healthcare. Lifesten Health’s AI-driven app not only offers a convenient way to monitor blood pressure but also integrates with broader wellness programs. Users can track physical activity, nutritional habits, mental wellness, and overall lifestyle patterns, earning rewards for consistent engagement. By combining diagnostic capability with behavioral insights, Lifesten creates a continuous feedback loop that supports long-term health improvements.

Looking Forward

While the Lifesten app is already transforming preventive health engagement, ongoing improvements to the TOI algorithms will further enhance accuracy and reliability. As Lifesten continues to innovate, the platform aims to expand digital screening capabilities, improve early detection of cardiovascular and metabolic conditions, and strengthen community-based health interventions across Africa.

Lifesten Health remains committed to making preventive healthcare digital, accessible, and impactful, empowering individuals, workplaces, and communities to take proactive steps toward healthier lives.

Read here https://journalspress.com/comparison-of-transdermal-optical-imaging-and-conventional-handcuff-methods-for-blood-pressure-screening-a-cross-sectional-study